Rajani Associates, a Mumbai based law firm has concluded private equity deal whereby New Silk Route has invested in Nectar Lifesciences Limited, listed on the Bombay Stock Exchange and the National Stock Exchange.
Nectar Lifesciences Limited a fast growing pharmaceutical company with ambitious plans to become market leader in the segment, also, intending to scale its share in $35-billion healthcare industry which would be touching $75 billion by 2012.
A fast track private equity deal in the listed entity was approx. USD 20 million fetching NSR Direct PE Mauritius LLC a significant minority stake in Nectar Lifesciences Limited.
Rajani Associate has advised the Company while Desai & Diwanji had advised the NSR Direct PE Mauritius LLC on structuring and negotiating the transaction on a time crunched private equity transaction to make it a win-win deal for all the parties with fast, focused and effective strategy.
No comments yet: share your views